BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 31607129)

  • 1. Effects of ME3 on the proliferation, invasion and metastasis of pancreatic cancer cells through epithelial-mesenchymal transition.
    Zhang Q; Li J; Tan XP; Zhao Q
    Neoplasma; 2019 Nov; 66(6):896-907. PubMed ID: 31607129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of PFTK1 inhibits tumor cell proliferation, invasion and epithelial-to-mesenchymal transition in pancreatic cancer.
    Zheng L; Zhou Z; He Z
    Int J Clin Exp Pathol; 2015; 8(11):14005-12. PubMed ID: 26823712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
    Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
    Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling.
    Xu M; He J; Li J; Feng W; Zhou H; Wei H; Zhou M; Lu Y; Zeng J; Peng W; Du F; Gong A
    Br J Cancer; 2017 Jan; 116(1):91-99. PubMed ID: 27898661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer.
    Li H; Wang X; Wen C; Huo Z; Wang W; Zhan Q; Cheng D; Chen H; Deng X; Peng C; Shen B
    Mol Cancer; 2017 Nov; 16(1):169. PubMed ID: 29121972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regulating NLRP3.
    Hu H; Wang Y; Ding X; He Y; Lu Z; Wu P; Tian L; Yuan H; Liu D; Shi G; Xia T; Yin J; Cai B; Miao Y; Jiang K
    Mol Cancer; 2018 Jan; 17(1):18. PubMed ID: 29386037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway.
    Xu X; Zhao Z; Guo S; Li J; Liu S; You Y; Ni B; Wang H; Bie P
    Cancer Lett; 2017 Jul; 397():12-22. PubMed ID: 28315433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole inhibits invasion and migration of pancreatic cancer cells by suppressing TGF-β/SMAD2/3 signaling.
    Chen K; Cheng L; Qian W; Jiang Z; Sun L; Zhao Y; Zhou Y; Zhao L; Wang P; Duan W; Ma Q; Yang W
    Oncol Rep; 2018 Apr; 39(4):1573-1582. PubMed ID: 29484419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial-Mesenchymal Transition.
    Lin C; Sun L; Huang S; Weng X; Wu Z
    Biomed Res Int; 2019; 2019():8042489. PubMed ID: 32258098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.
    Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P
    Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNX6 predicts poor prognosis and contributes to the metastasis of pancreatic cancer cells via activating epithelial-mesenchymal transition.
    Hu P; Liang Y; Hu Q; Wang H; Cai Z; He J; Cai J; Liu M; Qin Y; Yu X; Jiang C; Zhang B; Wang W
    Acta Biochim Biophys Sin (Shanghai); 2018 Nov; 50(11):1075-1084. PubMed ID: 30307473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer.
    Huang S; Huang C; Chen W; Liu Y; Yin X; Lai J; Liang L; Wang Q; Wang A; Zheng C
    Int J Oncol; 2018 Aug; 53(2):672-684. PubMed ID: 29845225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2.
    Zhang Z; Che X; Yang N; Bai Z; Wu Y; Zhao L; Pei H
    Biomed Pharmacother; 2017 Dec; 96():1341-1348. PubMed ID: 29196101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non‑coding RNA PVT1 promotes epithelial‑mesenchymal transition via the TGF‑β/Smad pathway in pancreatic cancer cells.
    Zhang X; Feng W; Zhang J; Ge L; Zhang Y; Jiang X; Peng W; Wang D; Gong A; Xu M
    Oncol Rep; 2018 Aug; 40(2):1093-1102. PubMed ID: 29845201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
    Meng F; Li W; Li C; Gao Z; Guo K; Song S
    Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer.
    Rumman M; Jung KH; Fang Z; Yan HH; Son MK; Kim SJ; Kim J; Park JH; Lim JH; Hong S; Hong SS
    Oncotarget; 2016 Nov; 7(47):78029-78047. PubMed ID: 27793006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer.
    Song Z; Feng C; Lu Y; Lin Y; Dong C
    Gene; 2018 Feb; 642():43-50. PubMed ID: 29128633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embigin is overexpressed in pancreatic ductal adenocarcinoma and regulates cell motility through epithelial to mesenchymal transition via the TGF-β pathway.
    Jung DE; Kim JM; Kim C; Song SY
    Mol Carcinog; 2016 May; 55(5):633-45. PubMed ID: 25773908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TM4SF1 as a prognostic marker of pancreatic ductal adenocarcinoma is involved in migration and invasion of cancer cells.
    Zheng B; Ohuchida K; Cui L; Zhao M; Shindo K; Fujiwara K; Manabe T; Torata N; Moriyama T; Miyasaka Y; Ohtsuka T; Takahata S; Mizumoto K; Oda Y; Tanaka M
    Int J Oncol; 2015 Aug; 47(2):490-8. PubMed ID: 26035794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.